
Sensus Healthcare: Global provider of non-invasive treatments for skin conditions using superficial radiation therapy.
Founded with a mission to revolutionize skin cancer treatment, Sensus Healthcare specializes in non-invasive therapies for non-melanoma skin cancers and other dermatological conditions like keloids. The company leverages superficial radiation therapy (SRT) to provide effective, patient-friendly alternatives to traditional surgical methods. Sensus Healthcare operates globally, aiming to make advanced skin treatments accessible and efficient for patients worldwide.
Notable figures affiliated with Sensus Healthcare include key medical professionals and industry experts who contribute to its innovative approach. The company has garnered significant investment from leading healthcare investors, bolstering its research and development efforts. Sensus Healthcare's achievements include the widespread adoption of its SRT systems in medical facilities around the world, significantly improving patient outcomes and setting new standards in dermatological care.

SkinCure Oncology

DermaSensor
dermasensor.com

Senseer Health
senseer.us

Sonalasense
sonalasense.com

Radiosight
radiosight.com

Strata Skin Sciences

Sense Diagnostics
senseneuro.com

Sensora
sensorahealth.com

Sensifree

V-Sense Medical

Sensys Medical

Dynosense
dynosense.com

Sentire Medical Systems
sentiremedical.com

LeviSense Medical

Singular Medical Technologies
Companies similar to Sensus Healthcare include SkinCure Oncology, DermaSensor, Senseer Health and Sonalasense.
Sensus Healthcare was founded in 2010.
Sensus Healthcare's headquarters is located in Boca Raton, FL, US.
Sensus Healthcare's most recent funding round was for $15M (USD) in September 2018.
As of Sep 17, 2018, Sensus Healthcare has raised a total of $25M (USD).
Sensus Healthcare has 37 employees as of Feb 6, 2024.